Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Andy Cohen has revealed he took a small dose of a "revolutionary" GLP-1 weight loss drug over the summer and lost 25 pounds.

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...

Initially marketed as diabetes treatments, GLP-1 drugs are now surging in popularity as weight loss solutions. With more ...

GLP-1 weight loss drugs like Ozempic and Mounjaro are booming, but their impact on gut health is raising critical questions.

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

There's virtually no published evidence that proves taking smaller-than-standard doses of the active ingredients in Zepbound ...

Alive News Investigates found a surprising number of people are getting their GLP-1 doses wrong, leading to an increase in ...